CEL-SCI Corporation Announces Closing of Public Offering for Gross Proceeds of $6 Million [Business Wire] - CEL-SCI Corporation , a late-stage oncology company, today announced that it has closed an underwritten public offering of 7,894,737 shares of common stock and 1,973,684 warrants to purchase shares of common stock. 10/24/2014 09:09 AM
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.